MS
COGT icon

Maven Securities’s Cogent Biosciences COGT Stock Holding History

Maven Securities’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$774K Buy
+20,000
New +$700K 0.02% 287
2026
Q1 		– Sell
-82,800
Closed -$2.94M – 424
2025
Q4 		$2.94M Buy
+82,800
New +$2.33M 0.06% 258
2021
Q2 		– Sell
-3,519
Closed -$31K – 1098
2021
Q1 		$31K Buy
+3,519
New +$33.9K ﹤0.01% 1121

Other funds holding COGT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Maven Securities's COGT Position: Q2 2026 in Review

Maven Securities opened a new position in Cogent Biosciences (COGT) in Q2 2026: 20,000 shares worth $774K. The stake represents 0.02% of the portfolio and ranks #287 among its holdings. This is a return to the name: Maven Securities previously reported a position in COGT as recently as Q4 2025.

Maven Securities first reported a position in COGT in Q1 2021 and has held it in 3 quarters since. The position peaked at $2.94M in Q4 2025. 324 funds tracked by Wall St. Rank hold COGT as of Q2 2026.

  • Maven Securities held 20,000 shares of Cogent Biosciences worth $774K as of Q2 2026.
  • Cogent Biosciences was a new Maven Securities position in Q2 2026.
  • Cogent Biosciences made up 0.02% of Maven Securities's portfolio in Q2 2026, its #287 holding.
  • Maven Securities first reported a position in Cogent Biosciences in Q1 2021 and has held it in 3 quarters since.
  • Maven Securities's Cogent Biosciences position peaked at $2.94M in Q4 2025.
  • 324 funds tracked by Wall St. Rank held Cogent Biosciences as of Q2 2026.

Based on Maven Securities's 13F filing for Q2 2026, filed 14 Aug 2026.